Urology Times: Dr. Aggarwal on study of androgen annihilation in biochemically relapsed prostate cancer

Submitted by UCSF Urology on September 22, 2022 at 12:00 am
Share to Facebook Share to Twitter Share via E-mail

Rahul Aggarwal, MD, discusses the phase 3 PRESTO trial, which he presented at the 2022 ESMO Congress.

Read more here.